BB Biotech

Update in progress

BION.SW (Swiss)

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in public equities worldwide, focusing on companies active in modern biotechnology for medicines and diagnostics. A fundamental analysis approach guides the portfolio construction. BB Biotech AG was established on November 9, 1993 and is domiciled in Switzerland.